Key result
ICD implantation linked to improved 4-year anxiety scores in genetic heart disease patients.
Why the study?
Prospective and long-term impacts on psychological functioning and health-related quality of life after ICD implantation in patients with genetic heart diseases are unknown.
Does implantable cardioverter defibrillator (ICD) implantation affect psychological functioning and health-related quality of life over time in patients with genetic heart diseases?
Cohort (n=40)
No
Does implantable cardioverter defibrillator (ICD) implantation affect psychological functioning and health-related quality of life over time in patients with genetic heart diseases?
p-value: p=0.017
While the majority of patients with genetic heart diseases adjust well to ICD implantation, a significant subset experiences elevated anxiety and depression, highlighting the need for targeted psychological support.
No takes yet. Share an insight, caveat, or question.
May indicate long-term anxiety benefits from ICDs in genetic heart diseases; leaves open targeted support needs for the subset with persistent elevation.
Heuvel et al. (2021) conducted a cohort in Genetic heart diseases (n=40). Implantable cardioverter defibrillator (ICD) vs. Baseline was evaluated on Change in HADS anxiety score at 4 years compared to baseline (95% CI -14.05- -2.87, p=0.017). In patients with genetic heart diseases, ICD implantation was associated with a significant improvement in anxiety scores after 4 years compared to baseline.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: